Get my own profile
Public access
View all16 articles
4 articles
available
not available
Based on funding mandates
Co-authors
- Antoine HollebecqueConsultant, Gustave Roussy Cancer Campus, VillejuifVerified email at gustaveroussy.fr
- Funda Meric-BernstamChair, Department of Investigational Cancer Therapeutics, The UT MD Anderson Cancer CenterVerified email at mdanderson.org
- christophe massardUniversité Paris-Saclay, Faculté de Médecine, Drug Development Department (DITEP), Gustave RoussyVerified email at gustaveroussy.fr
- Davide MelisiAssociate professor, University of VeronaVerified email at univr.it
- Gianluigi GiannelliDirettore Scientifico IRCCS "Saverio de Bellis"Verified email at irccsdebellis.it
- Jordi RodonMD Anderson Cancer CenterVerified email at mdanderson.org
- Jean-Charles SoriaAmgen R&DVerified email at amgen.com
- François LokiecInstitut CurieVerified email at curie.fr
- Hendrik-Tobias ArkenauEllipses PharmaVerified email at ellipses.life
- Gaël DEPLANQUEMedical Oncologist, CHUV & UNIL, Lausanne University, SwitzerlandVerified email at hopitalrivierachablais.ch
- Jason R. ManroResearch Scientist, Eli Lilly and CompanyVerified email at lilly.com
- Steven M OgbourneUniversity of the Sunshine CoastVerified email at usc.edu.au
- Ulrik Lassen, Professor, MD, PH.D.Phase 1 Unit, Department of OncologyVerified email at regionh.dk
- Emiliano CalvoSTART Madrid-HM CIOCCVerified email at startmadrid.com
- Jaime R MerchanTenured Professor of Medicine, University of Miami Miller School of MedicineVerified email at med.miami.edu
- Sandaruwan GeeganageIncyte CorporationVerified email at incyte.com
- Danni YuNektar Therapeutics, Eli Lilly and Company, Purdue UniversityVerified email at nektar.com
- Greg PlowmanVP Oncology Research, LillyVerified email at imclone.com
- Kohei ShitaraNational Cancer Center Hospital EastVerified email at east.ncc.go.jp
- Peter GalleProfessor für Medizin, Mainz UniversityVerified email at uni-Mainz.de